Levy B, Barlesi F, Paz-Ares L, Bennouna J, et al. Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO). Lung Cancer 2022;166:107-113.
PMID: 35257949